February 26-28, 2020 - IABS To Celebrate 65th Anniversary
SAVE THE DATE
IABS 65th Anniversary
IABS will celebrate its 65th Anniversary on February 26-28, 2020, in Lyon, France.
More information coming very soon....
December 2-3, 2019 - Rockville, Maryland
2nd Setting Specifications for Biological Products: A Pathway to Harmonization
December 3-4, 2019 - Bangkok, Thailand
Animal Testing for Vaccines
Implementing Replacement, Reduction and Refinement:
Challenges and Priorities
February 6-7, 2020 - Pembroke College - Oxford, United Kingdom
3rd Human Challenge Trials in Vaccine Development
SAVE THE DATE
Register for the Conference Here
This workshop builds on the successes and identified challenges from two prior workshops on the subject of human challenge trials or controlled human infection models (CHIM). When CHIM are used to inform vaccine development, they can add to what is known from natural history, epidemiology, and pathogenesis studies to speed the vaccine development pathway. However, there are significant safety, ethical, operational, environmental, and scientific issues in intentionally infecting humans with infectious organisms in controlled settings of clinical trials. Nonetheless, these trials can be performed safely and ethically both in non-endemic and endemic regions. Attend this workshop to learn more about these challenging issues and to join in the conversation that will lead to progress and recommendations for enhancing CHIM as tools to develop new and improved vaccines
More information about this meeting soon....
March 16-17, 2020 - Royal Academy, Brussels, Belgium
Cross learning experience human and animal vaccine licensure
based on technology platforms
‘Platform Meeting IABS CEPI’
SAVE THE DATE
IABS is a non-for-profit organisation working for many years on dialogue between regulators, academia and industry on scientific topics. Its European affiliate IABS-EU is a partner in the IMI project ZAPI where the discussion is on the table on how the development of platform technologies for vaccines can improve preparedness for emerging diseases.
The idea of the symposium is to discuss with the regulators the potential benefit of creating a specific registration procedure for Vaccine platform technology.
CEPI (Coalition for Epidemic Preparedness Innovations) is non-for-profit organisation that is working in the field of development of neglected and emerging diseases and would like to help the discussion to shorten the development time for vaccines against these diseases with particular emphasis on platform technologies. Several vaccine projects sponsored by CEPI face obvious difficulties in the conduct of clinical trials. However, pushing vaccine development as far as possible to be ready timely in outbreak situations also supposes consideration and support from authorities, keeping safety of the at exposed population as a priority.